AZ505 Catalog No.:M9501-10 Smiles: CC1CC2=CC(OC)=C(OC)C(OC)=C2C2=C(OC)C(OC)=C(C=C2CC1C)OC

Smiles: CC1CC2=CC(OC)=C(OC)C(OC)=C2C2=C(OC)C(OC)=C(C=C2CC1C)OC

1446321-46-5

AY 77 exhibits bias for Ca2+ over ERK1/2 signaling (EC50 values are 40 nM for Ca2+ release versus 2 μM for ERK1/2 phosphorylation)

AMD 3465 may be useful for the clinical treatment of HIV-1-infected patients

which has been shown to occur in human myoblasts and other cells[2]

AZ505 Catalog No.:M9501-10 Smiles: CC1CC2=CC(OC)=C(OC)C(OC)=C2C2=C(OC)C(OC)=C(C=C2CC1C)OCAZ505 is a potent and highly selective inhibitor of SMYD2 with potential anticancer activity. AZ505 is composed of three distinct moieties: benzooxazinone, cyclohexyl, and dichlorophenethyl substituents. The structure of the ternary complex reveals that a single AZ505 molecule is bound in the peptide binding groove of SMYD2. Product information CAS Number: 1035227 43 0 Molecular Weight: 577. 54 Formula: C29H38Cl2N4O4 Chemical Name: N cyclohexyl 3 {[2